209 related articles for article (PubMed ID: 10446115)
21. Autoantibodies in chronic liver disease.
Ghonaim M; Al-Ghamdi A; El-Bana H; Bakr A; Ghoneim E; El-Edel R; Hassona M; Shoeib S; Allam H
Egypt J Immunol; 2005; 12(2):101-11. PubMed ID: 17977215
[TBL] [Abstract][Full Text] [Related]
22. Is hepatitis C virus a risk factor for thyroid autoimmunity?
Floreani A; Betterle C; Carderi I; Presotto F; Pedini B; Moscon A; Andrea O; Chiaramonte M;
J Viral Hepat; 2006 Apr; 13(4):272-7. PubMed ID: 16611194
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype.
Luo JC; Hwang SJ; Li CP; Lu RH; Chan CY; Wu JC; Chang FY; Lee SD
J Gastroenterol Hepatol; 1998 May; 13(5):475-9. PubMed ID: 9641643
[TBL] [Abstract][Full Text] [Related]
24. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia.
Zusinaite E; Metskula K; Salupere R
World J Gastroenterol; 2005 Jan; 11(4):488-91. PubMed ID: 15641131
[TBL] [Abstract][Full Text] [Related]
26. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
27. Non-organ-specific autoantibodies in Indian patients with chronic liver disease.
Daschakraborty S; Aggarwal A; Aggarwal R
Indian J Gastroenterol; 2012 Sep; 31(5):237-42. PubMed ID: 22941677
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.
Lirussi F; Beccarello A; Bortolato L; Morselli-Labate AM; Crovatto M; Ceselli S; Santini G; Crepaldi G
Liver; 1999 Oct; 19(5):381-8. PubMed ID: 10533795
[TBL] [Abstract][Full Text] [Related]
29. Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
Rostaing L; Modesto A; Cisterne JM; Izopet J; Oksman F; Duffaut M; Abbal M; Durand D
Am J Nephrol; 1998; 18(1):50-6. PubMed ID: 9481439
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.
Ferri S; Muratori L; Quarneti C; Muratori P; Menichella R; Pappas G; Granito A; Ballardini G; Bianchi FB; Lenzi M
J Hepatol; 2009 Jun; 50(6):1093-101. PubMed ID: 19398235
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of a variety of autoantibodies in a population of hepatitis C virus-infected individuals.
Navarta LM; Espul CA; Acosta-Rivero N
APMIS; 2018 Jun; 126(6):515-522. PubMed ID: 29924449
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
[TBL] [Abstract][Full Text] [Related]
34. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey].
Aktaş E; Ogedey ED; Külah C; Beğendik Cömert F
Mikrobiyol Bul; 2010 Oct; 44(4):647-50. PubMed ID: 21063977
[TBL] [Abstract][Full Text] [Related]
35. [Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients].
Küçköztaş MF; Ozgünes N; Yazici S
Mikrobiyol Bul; 2010 Jan; 44(1):111-5. PubMed ID: 20455406
[TBL] [Abstract][Full Text] [Related]
36. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients.
Komatsu F; Takasaki K
Liver; 1999 Oct; 19(5):375-80. PubMed ID: 10533794
[TBL] [Abstract][Full Text] [Related]
37. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
39. High frequency of smooth muscle antibodies (SMA) among HCV positive chronic liver disease patients in Egypt.
El-Zayadi A; Selim O; Dabbous HK; Bianchi F
J Egypt Public Health Assoc; 1994; 69(3-4):205-11. PubMed ID: 17265638
[TBL] [Abstract][Full Text] [Related]
40. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
